• Filipin III: Precision Mapping of Membrane Cholesterol in...

  2025-10-01

  Explore how Filipin III, a cholesterol-binding fluorescent antibiotic, enables quantitative, ultrastructural analysis of cholesterol distribution in cell membranes. This in-depth guide introduces advanced strategies for linking membrane cholesterol visualization to metabolic dysfunction studies, offering technical, application-focused insights beyond existing literature.

• Deferasirox: Redefining Iron Chelation and Ferroptosis Mo...

  2025-09-30

  Explore how Deferasirox, a leading oral iron chelator, uniquely modulates iron metabolism and ferroptosis pathways for advanced cancer therapy. This article unveils new research directions and mechanistic insights, setting it apart from existing resources.

• AZD0156: Advancing ATM Kinase Inhibitor Research in DNA R...

  2025-09-29

  Discover how AZD0156, a potent ATM kinase inhibitor, is revolutionizing cancer research by enabling precise interrogation of DNA damage response and metabolic adaptation. This article uniquely integrates molecular mechanism, translational insights, and strategic research applications for selective ATM inhibition.

• SP600125: A Next-Generation JNK Inhibitor for Phosphoprot...

  2025-09-28

  Explore the advanced scientific potential of SP600125 as a selective JNK inhibitor in phosphoproteomic profiling and translational research. This article uniquely examines SP600125's utility for dissecting kinase networks beyond canonical pathways, offering insights distinct from standard inflammation and cancer studies.

• Clozapine N-oxide (CNO): Precision Chemogenetics for Circ...

  2025-09-27

  Discover how Clozapine N-oxide (CNO), a metabolite of clozapine, enables unprecedented specificity in chemogenetic circuit modulation and translational neuroscience. This in-depth review explores advanced mechanisms, novel applications, and unique translational insights beyond current literature.

• Next-Generation Genome Editing: EZ Cap™ Cas9 mRNA (m1Ψ) f...

  2025-09-26

  Explore how EZ Cap™ Cas9 mRNA (m1Ψ) leverages advanced mRNA capping and N1-Methylpseudo-UTP modifications to optimize CRISPR-Cas9 genome editing in mammalian cells. This in-depth analysis reveals novel strategies for regulatory control, immune evasion, and enhanced editing fidelity.

• Biotin (Vitamin B7): Molecular Mechanisms in Motor Protei...

  2025-09-25

  Discover the intricate roles of Biotin (Vitamin B7) as a water-soluble B-vitamin in metabolic regulation and protein biotinylation. This article uniquely explores the molecular mechanism of biotin in motor protein activation and advanced research applications, offering insights beyond conventional overviews.

• Protease Inhibitor Cocktail EDTA-Free: Redefining Protein...

  2025-09-24

  Discover how the Protease Inhibitor Cocktail EDTA-Free safeguards protein integrity in advanced post-transcriptional and epigenetic studies. Explore unique insights into protein extraction protease inhibition, compatibility with phosphorylation analysis, and novel intersections with RNA modification research.

• Anti Reverse Cap Analog (ARCA): Enhancing mRNA Stability ...

  2025-09-23

  Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G serves as a pivotal mRNA cap analog for enhanced translation and stability in synthetic mRNA-based cell reprogramming. This article provides a rigorous analysis of ARCA's application in mRNA therapeutics research and its emerging role in translational control.

• In our previous report we synthesized

  2025-04-22

  

  In our previous report, we synthesized derivatives with some straight chain residues on the 2-position of the 3-cyanopyridine ring of compound 1. In this time we tried to introduce aromatic ring on the chain of the 2-position. Namely, we replaced the hydroxyl-alkylamino group in the position 2 of t

• The identification of novel kinase inhibitor scaffolds is hi

  2025-04-22

  

  The identification of novel kinase inhibitor scaffolds is highly desirable in order to develop selective kinase inhibitors. Small-molecule inhibitors of Interleukin-2-inducible T-cell kinase (Itk) that are based on the 3-aminopyridin-2-one fragment 1 have been reported. Despite derivatisation of 1 y

• br Aurora A Aurora B and Aurora

  2025-04-21

  

  Aurora-A, Aurora-B and Aurora-C small molecule inhibitors Nicholas et al. described phenotypic cellular screening of new highly potent and selective class of Aurora kinase inhibitors. Fragment based approach was utilized; core structure of 57 (Fig. 5) was optimized and selective inhibitor 58 (Fig

• Phosphoinositide kinase PI K Akt has been well demonstrated

  2025-04-19

  

  Phosphoinositide 3-kinase (PI3K)/Akt has been well demonstrated in the protection of myocardial cell against IR injury via increasing cardiomyocyte survival, inhibiting excessive autophagy, et al. (Kong et al., 2016). The 2X Taq PCR Master Mix (with dye) of ERK1/2 also involves in the regulation of

• The evidence points toward a role

  2025-04-18

  

  The evidence points toward a role for 12/15-LO activity in WAT in modulating chronic local inflammation and subsequent systemic metabolic decline in the obese state. However, little is known as to the role of 12- and 15-LOs in BAT. Indeed, in addition to WAT, platelet- and leukocyte-type 12-LO are e

• Somatostatin analogs also bind to somatostatin receptors

  2025-04-16

  

  Somatostatin analogs also bind to somatostatin receptors. It has been reported that octreotide has a high affinity for hSSTR2, moderate affinity for hSSTR3 and hSSTR5, and does not bind to hSSTR1 or hSSTR4 (Ben-Shlomo and Melmed 2008). Compared to octreotide, pasireotide displays 40-, 30-, and 5-fol

16389 records 5/1093 page Previous Next 12345 下5页 Last page